PT Pyridam Farma Tbk (PYFA.JK)
IDR 177.0
(-1.12%)
IDR 177.0
(-1.12%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 282.01 Billion IDR | 12.43% |
| 2022 | 250.84 Billion IDR | 2.56% |
| 2021 | 244.58 Billion IDR | 49.23% |
| 2020 | 163.89 Billion IDR | 16.9% |
| 2019 | 140.2 Billion IDR | -7.21% |
| 2018 | 151.1 Billion IDR | 11.95% |
| 2017 | 134.97 Billion IDR | -0.25% |
| 2016 | 135.31 Billion IDR | -1.93% |
| 2015 | 137.98 Billion IDR | -2.38% |
| 2014 | 141.34 Billion IDR | 8.37% |
| 2013 | 130.43 Billion IDR | 12.76% |
| 2012 | 115.67 Billion IDR | 13.86% |
| 2011 | 101.59 Billion IDR | 13.16% |
| 2010 | 89.77 Billion IDR | 6.57% |
| 2009 | 84.24 Billion IDR | 7.5% |
| 2008 | 78.36 Billion IDR | 40.87% |
| 2007 | 55.63 Billion IDR | 38.24% |
| 2006 | 40.24 Billion IDR | 71.94% |
| 2005 | 23.4 Billion IDR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 87.77 Billion IDR | 48.61% |
| 2024 Q3 | 137.04 Billion IDR | 56.13% |
| 2024 Q1 | 59.06 Billion IDR | -15.05% |
| 2023 Q4 | 69.52 Billion IDR | -19.37% |
| 2023 Q2 | 63.6 Billion IDR | -13.33% |
| 2023 Q3 | 86.22 Billion IDR | 35.57% |
| 2023 Q1 | 73.38 Billion IDR | 9.21% |
| 2023 FY | 282.01 Billion IDR | 12.43% |
| 2022 Q2 | 53.45 Billion IDR | -31.32% |
| 2022 Q4 | 67.19 Billion IDR | 28.32% |
| 2022 FY | 250.84 Billion IDR | 2.56% |
| 2022 Q1 | 77.83 Billion IDR | 72.79% |
| 2022 Q3 | 52.36 Billion IDR | -2.04% |
| 2021 Q4 | 45.04 Billion IDR | -46.03% |
| 2021 Q2 | 50.67 Billion IDR | -22.52% |
| 2021 Q1 | 65.4 Billion IDR | 41.26% |
| 2021 Q3 | 83.45 Billion IDR | 64.68% |
| 2021 FY | 244.58 Billion IDR | 49.23% |
| 2020 Q2 | 27.84 Billion IDR | -43.5% |
| 2020 FY | 163.89 Billion IDR | 16.9% |
| 2020 Q4 | 46.3 Billion IDR | 14.47% |
| 2020 Q3 | 40.44 Billion IDR | 45.25% |
| 2020 Q1 | 49.29 Billion IDR | 40.75% |
| 2019 Q1 | 38.35 Billion IDR | 2.65% |
| 2019 FY | 140.2 Billion IDR | -7.21% |
| 2019 Q4 | 35.02 Billion IDR | 0.32% |
| 2019 Q3 | 34.9 Billion IDR | 9.37% |
| 2019 Q2 | 31.91 Billion IDR | -16.78% |
| 2018 FY | 151.1 Billion IDR | 11.95% |
| 2018 Q4 | 37.36 Billion IDR | -2.96% |
| 2018 Q3 | 38.5 Billion IDR | 7.99% |
| 2018 Q2 | 35.65 Billion IDR | -9.91% |
| 2018 Q1 | 39.57 Billion IDR | 24.08% |
| 2017 Q2 | 32.52 Billion IDR | -1.11% |
| 2017 Q1 | 32.89 Billion IDR | -5.1% |
| 2017 Q3 | 37.66 Billion IDR | 15.79% |
| 2017 FY | 134.97 Billion IDR | -0.25% |
| 2017 Q4 | 31.89 Billion IDR | -15.3% |
| 2016 Q3 | 27.26 Billion IDR | -32.16% |
| 2016 Q4 | 34.65 Billion IDR | 27.12% |
| 2016 FY | 135.31 Billion IDR | -1.93% |
| 2016 Q2 | 40.18 Billion IDR | 21.03% |
| 2016 Q1 | 33.2 Billion IDR | -7.41% |
| 2015 Q4 | 35.86 Billion IDR | 24.92% |
| 2015 FY | 137.98 Billion IDR | -2.38% |
| 2015 Q2 | 36.37 Billion IDR | -1.8% |
| 2015 Q1 | 37.04 Billion IDR | -5.69% |
| 2015 Q3 | 28.7 Billion IDR | -21.07% |
| 2014 FY | 141.34 Billion IDR | 8.37% |
| 2014 Q1 | 35.51 Billion IDR | -2.87% |
| 2014 Q2 | 32.5 Billion IDR | -8.48% |
| 2014 Q4 | 39.27 Billion IDR | 15.35% |
| 2014 Q3 | 34.04 Billion IDR | 4.75% |
| 2013 Q4 | 36.56 Billion IDR | -2.79% |
| 2013 Q2 | 27.09 Billion IDR | -7.06% |
| 2013 Q1 | 29.15 Billion IDR | -5.56% |
| 2013 FY | 130.43 Billion IDR | 12.76% |
| 2013 Q3 | 37.61 Billion IDR | 38.82% |
| 2012 Q1 | 31.17 Billion IDR | 21.36% |
| 2012 FY | 115.67 Billion IDR | 13.86% |
| 2012 Q3 | 26.9 Billion IDR | 0.67% |
| 2012 Q4 | 30.86 Billion IDR | 14.74% |
| 2012 Q2 | 26.72 Billion IDR | -14.27% |
| 2011 Q2 | 24.18 Billion IDR | -9.82% |
| 2011 Q4 | 25.68 Billion IDR | 3.18% |
| 2011 Q1 | 26.81 Billion IDR | 0.0% |
| 2011 Q3 | 24.89 Billion IDR | 2.94% |
| 2011 FY | 101.59 Billion IDR | 13.16% |
| 2010 FY | 89.77 Billion IDR | 6.57% |
| 2009 FY | 84.24 Billion IDR | 7.5% |
| 2008 FY | 78.36 Billion IDR | 40.87% |
| 2007 FY | 55.63 Billion IDR | 38.24% |
| 2006 FY | 40.24 Billion IDR | 71.94% |
| 2005 FY | 23.4 Billion IDR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 942.41 Billion IDR | 70.075% |
| PT Merck Tbk | 391.72 Billion IDR | 28.008% |
| PT Phapros, Tbk | 533.85 Billion IDR | 47.174% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 2018.69 Billion IDR | 86.03% |
| PT Tempo Scan Pacific Tbk | 4513.76 Billion IDR | 93.752% |